Surveillance of hepatitis C
Learn about hepatitis C surveillance.
On this page
- How many cases are there of hepatitis C in Canada?
- How many cases are there of hepatitis C around the world?
- How does Canada monitor hepatitis C?
- For more information
How many cases are there of hepatitis C in Canada?
In 2018, the overall reported rate of hepatitis C infection in Canada was 33.6 cases per 100,000 people.
The Public Agency of Canada estimated that there were 317,100 people in Canada who ever had hepatitis C in 2017. Of these, an estimated 194,500 people were living with chronic hepatitis C.
How many cases are there of hepatitis C around the world?
According to the World Health Organization, globally, 130 million to 150 million people have chronic hepatitis C infection.
Approximately 500,000 people die each year from hepatitis C-related liver diseases.
How does Canada monitor hepatitis C?
The Public Health Agency of Canada collects and publishes data on reported cases of hepatitis C received:
- from the provinces and territories
- through the Canadian Notifiable Disease Surveillance System (CNDSS)
Additional data is collected and analyzed through partnerships with:
- other federal departments
- local public health departments
For more information
Canada Communicable Disease Report
- "Hepatitis C Surveillance in Canada"
- "Distribution of Hepatitis C Virus Genotypes Among Newly Acquired HCV Infections in British Columbia (2000-2013)"
- "Impact of availability of direct-acting antivirals for hepatitis C on Canadian hospitalization rates, 2012-2016"
- "Estimated Prevalence of Hepatitis C Virus Infection in Canada, 2011"
- "Hepatitis C Virus Transmission in the Prison/Inmate Population"
- Seroprevalence of Hepatitis B and C Virus Infections: Results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey
- Report on Hepatitis B and C in Canada: 2018
- Report on Hepatitis B and C in Canada:2017
- Report on Hepatitis B and C in Canada:2016
- Report on Hepatitis B and C in Canada:2014
- Report on Hepatitis B and C in Canada:2013
- Testing and Treatment for Human Immunodeficiency Virus and Hepatitis C Virus Infections Among Canadian Federal Inmates
- I-Track: Enhanced surveillance of HIV, hepatitis C, and associated risk behaviours among people who inject drugs in Canada. Phase 3 (2010-2012) Report
- Summary of Key Findings from Y-Track Phase 6 (2009-2012)
- Hepatitis C in Canada: 2005-2010 Surveillance Report
- Hepatitis C Virus Infection in Canadian Street Youth: The Role of Injection Drug Use
- National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019
Report a problem or mistake on this page
- Date modified: